Methylenedioxyanilino-quinazolines and -cyanoquinolines as inhibitors of MEK and/or Src

Author:  

Publisher: Informa Healthcare

ISSN: 1354-3776

Source: Expert Opinion on Therapeutic Patents, Vol.14, Iss.7, 2004-07, pp. : 1095-1100

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract